Hepatitis B Virus Alters the Antioxidant System in Transgenic Mice and Sensitizes Hepatocytes to Fas Signaling by Wang, Qian et al.
Hepatitis B Virus Alters the Antioxidant System in
Transgenic Mice and Sensitizes Hepatocytes to Fas
Signaling
Qian Wang
1,2, Bing Na
1,2, Jing-hsiung James Ou
3, Lynn Pulliam
4*, T. S. Benedict Yen
1,2{
1Department of Pathology, University of California San Francisco, San Francisco, California, United States of America, 2Pathology Service 113B, VA Medical Center, San
Francisco, California, United States of America, 3Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, California, United
States of America, 4Department of Laboratory Medicine, University of California San Francisco, VA Medical Center, San Francisco, California, United States of America
Abstract
Hepatitis B virus (HBV) is a major etiological factor of hepatocellular carcinoma (HCC). However, the precise pathogenetic
mechanisms linking HBV infection and HCC remain uncertain. It has been reported that decreased antioxidant enzyme
activities are associated with severe liver injury and hepatocarcinogenesis in mouse models. It is unclear if HBV can interfere
with the activities of antioxidant enzymes. We established a HBV transgenic mouse line, which spontaneously developed
HCC at 2 years of age. We studied the activities of the antioxidant enzymes in the liver of the HBV transgenic mice. Our
results showed that the antioxidant enzymes glutathione peroxidase and superoxide dismutase 2 were down-regulated in
HBV transgenic mice and correlated with JNK activation. HBV enhanced the Fas-mediated activation of caspase 6, caspase 8
and JNK without enhancing the activation of caspase 3 and hepatocellular apoptosis. As a proper redox balance is
important for maintaining cellular homeostasis, these effects of HBV on the host antioxidant system and Fas-signaling may
play an important role in HBV-induced hepatocarcinogenesis.
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Introduction
Intracellular reactive oxygen species (ROS) levels are tightly
controlled by four primary antioxidant enzymes superoxide
dismutase (SOD) 1 and 2 (CuZnSOD and MnSOD), glutathione
peroxidase (GPx) and catalase. Superoxide radicals are converted
into hydrogen peroxide by SOD 1 and 2, and hydrogen peroxide
is converted into water by catalase and GPx [1,2]. Oxidative stress
can result from increased production of ROS and/or diminished
levels of antioxidants including the activities of antioxidant
enzymes [3].
Hepatocellula carcinoma (HCC) is the third leading cause of
cancer death [4]. There are several published reports to show that
decreased antioxidant enzyme activities are associated with severe
liver injury and hepatocarcinogenesis in mouse models. For
example, SOD1 deficient (Sod12/2) mice have increased
incidence to develop liver nodular hyperplasia or HCC [5]. GPx
deficient (Gpx2/2) mice are more susceptible to liver injury-
induced by tumor necrosis factor a (TNFa), anti-Fas antibody and
oxidant paraquat [6,7,8]. Moreover, when challenged with
oxidant paraquat, C-Jun amino-terminal kinases (JNK) are more
activated in GPx deficient mice than in wild type mice [7]. The
correlation between aberrant activation of JNK and hepatocar-
cinogenesis is observed in liver-specific deletion of p38a and IKKb
mouse models [9,10]. In a liver-specific deletion of IKKb mouse
model, diethylnitrosamine (DEN)-induced ROS production may
contribute to sustained JNK activation due to oxidation and
inhibition of JNK-inactivating phosphatases [11]. JNK1 has also
been reported to be activated in human HCC tissues compared to
adjacent non-cancerous tissues, among which 70% are with
hepatitis B virus (HBV) infection. However, the mechanism for
JNK1 activation is unknown [12].
Both HBV and hepatitis C virus (HCV) are the major
etiological factors of HCC [13,14]. Lipid peroxidation has been
detected in both HBV and HCV chronically infected patients,
especially those with cirrhosis [15,16]. Both in vitro and in vivo
evidences demonstrate that HCV core protein can induce ROS
production and corresponding elevated antioxidant response as
shown by up-regulation of the mRNA of antioxidant genes,
including GPx, increased catalase activity and decreased total and
reduced glutathione level [17,18]. However, it is unclear if HBV
can interfere with the activities of antioxidant enzymes.
We established a HBV transgenic mouse line, which carries the
1.3 mer over-length HBV genome and productively replicates
HBV in the liver. Due to immune tolerance, the HBV transgenic
mice do not have liver inflammation until they spontaneously
develop HCC at 2 years of age [19,20]. We studied the activation
of JNK and the activities of the antioxidant enzymes in the liver of
the HBV transgenic mice. We found that both JNK1 and JNK2
were activated in the liver of the HBV transgenic mice. The
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36818activation of JNK was correlated with the down-regulation of the
antioxidant enzymes SOD2 and GPx. The altered antioxidant
enzyme system sensitized the HBV transgenic mice to the Fas
signaling pathway.
Results
Activation of JNK in HBV transgenic mice
The HBV transgenic mice spontaneously develop hepatocellu-
lar neoplasms, including HCC at two years of age [19]. Since
activation of JNK has been observed in HCC mouse models and
HCC patients [9,10,12], five HBV transgenic mice and seven non-
transgenic control mice at two years of age were carefully
identified by genotyping and chosen to study the activation of
JNK in the liver. All of the five HBV transgenic mice developed
HCC. Representative hematoxylin and eosin stained sections of
HBV transgenic mouse liver with HCC and non-transgenic
control mouse liver are shown in Fig. S1. First, we determined
whether or not JNK is activated in the liver of 2-year-old HBV
transgenic mice, which developed HCC, and non-transgenic
control mice by analyzing the levels of JNK1, JNK2 and their
activated forms (i.e., p-JNK1 and p-JNK2) by Western blot
(Fig. 1A). There was no significant difference of total JNK1 and
JNK2 levels between control mice and HBV transgenic mice.
However, when the levels of p-JNK1 and p-JNK2 were quantified
and normalized against their respective total JNKs, higher levels of
p-JNK1 and p-JNK2 were detected in HBV transgenic mice
(P,0.01) (Fig. 1B). Secondly, we analyzed the protein levels of
phosphorylated c-Jun and total c-Jun in the same mice. c-Jun is
one of the targets of activated JNK and demonstrated to be
essential for development of liver tumors [23,24]. Phosphorylated
c-Jun can bind to its own promoter and enhance its own
expression [25,26]. As shown in Fig. 1C, among the five HBV
transgenic mice, three of them showed increased phosphorylated
c-Jun and four of them showed increased total c-Jun compared to
control mice.
Down-regulation of antioxidant enzymes GPx and SOD2
in HBV transgenic mice
Since increased ROS production and decreased antioxidant
defenses have been reported to be beneficial to activation of JNK
[7,10,11], we examined antioxidant enzymes and lipid peroxida-
tion in the liver of the same control and HBV transgenic mice as
described above. First, we analyzed the protein levels of the
antioxidant enzymes SOD1, SOD2, GPx and catalase. As shown
in Fig. 2A and 2B, the protein levels of both GPx and SOD2 were
lower in HBV transgenic mice than in control mice. The relative
intensity (RI) of GPx or SOD2 to actin was calculated for
individual mice and the mean was shown in Fig. 2C. The down-
regulation of both GPx and SOD2 in HBV transgenic mice was
statistically significant. Our results suggested that down-regulation
of Gpx and SOD2 was correlated with activation of JNK in the
liver of HBV transgenic mice.
To confirm these results, we also measured the enzyme activities
of GPx and SOD2 in the mouse livers. The enzyme activities of
GPx and SOD2 are shown in Table 1. The GPx and SOD2
activities were reduced by 70% and 20%, respectively, in HBV
transgenic mice (Fig. 2D). The reduction of GPx activity, but not
SOD2 activity in HBV transgenic mice was statistically significant.
In contrast to GPx and SOD2, the expression levels of SOD1 and
catalase were not significantly different between control mice and
HBV transgenic mice (data not shown).
To further investigate whether HBV has a direct effect on the
expression levels of GPx and SOD2 in cell cultures, we transfected
the HBV genome into the human hepatoma cell lines C3A and
HuH-7. As shown in Fig. 3, the transfection of the HBV DNA
genome reduced the expression of GPx but not SOD2 in C3A
cells. These data indicated that HBV could directly suppress the
expression of GPx but not SOD2 in C3A cells. We did not observe
reduced expression of GPx and SOD2 in HuH-7 cells (data not
shown).
Figure 1. Activation of JNK in the liver of 2-year old HBV transgenic mice. (A) Western blot analysis of phosphorylated and total JNK in
control (n=7) and HBV transgenic (n=5) mice. (B) Quantification of the activation of JNK1 and JNK2 (mean 6 SEM) in control and HBV transgenic
mice described in (A). Significant differences between control and HBV transgenic mice are indicated by two (P,0.01) asterisks. (C) Western blot
analysis of phosphorylated and total c-Jun in the same control and HBV transgenic mice as described in (A).
doi:10.1371/journal.pone.0036818.g001
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peroxidation between control mice and HBV transgenic mice by
measuring the levels of malondialdehyde (MDA) and found there
was no difference in MDA levels between control mice and HBV
transgenic mice (Table 1), indicating there was no lipid
peroxidation in the liver of HBV transgenic mice.
Enhancement of Fas-mediated activation of JNK in HBV
transgenic mice
It has been reported that TNFa, anti-Fas antibody and oxidant
paraquat can cause more severe liver injury in GPx-deficient
(Gpx2/2) mice than in wild-type mice and JNK is more activated
in paraquat-induced liver aponecrosis [6,7,8]. It has also been
reported that anti-Fas antibody by intravenous injection will
induce ROS production in the liver of the mouse [27]. We injected
control and HBV transgenic mice intravenously with anti-Fas
antibody Jo2, and investigated whether HBV transgenic mice were
more susceptible to anti-Fas antibody-induced hepatocellular
apoptosis. We also investigated the protein levels and enzyme
activities of GPx, SOD2 and activation of JNK in this process. We
Figure 2. Down-regulation of antioxidant enzymes GPx and SOD2 in HBV transgenic mice. (A) Western blot analysis of GPx in the liver of
the same control and HBV transgenic mice as described in Figure 1. Relative intensity (RI) refers to the intensity of GPx normalized to that of actin,
which was used as the loading control. (B) Western blot analysis of SOD2 in the liver of the same control and HBV transgenic mice as described in
Figure 1. RI refers to the intensity of SOD2 relative to that of actin. (C) Mean values of the RIs of GPx (mean 6 SEM) and SOD2 (mean 6 SEM) in control
and HBV transgenic mice described in (A) and (B). Significant differences between control and HBV transgenic mice are indicated by three (P,0.0001)
and two (P,0.01) asterisks. (D) Relative enzymatic activities of GPx and SOD2 in the same control and HBV transgenic mice as described in (A) and (B).
The enzyme activities of GPx and SOD2 in the liver of control and HBV transgenic mice were measured and normalized to the protein concentrations.
The enzyme activities of the control mice were arbitrarily defined as 100% (mean 6 SEM). Significant differences between control and HBV transgenic
mice are indicated by three asterisks (P,0.0001).
doi:10.1371/journal.pone.0036818.g002
Table 1. Enzyme activities of GPx, SOD2 and MDA in the liver
of control and HBV transgenic mice.
GPx SOD2 MDA
(U/mg protein) (U/mg protein) (mM/mg protein)
Control (n=7) 2.560.0 5.760.1 1.160.1
tg (n=5) 0.860.1
*** 4.660.2 1.160.1
Values are mean 6 SEM; significant difference between control and HBV
transgenic mice are indicated by three asterisks (P,0.0001). tg=HBV transgenic
mice.
doi:10.1371/journal.pone.0036818.t001
Figure 3. Suppression of GPx by HBV in C3A human hepatoma
cells line. C3A cells transiently transfected with pHBV1.3 or empty
vector for 48 h were lysed for Western blot analysis for HBV small
surface proteins (glycosylated/unglycosylated, gp27/p24), GPx and
SOD2. a-tubulin was also analyzed to serve as a loading control. The
RIs of GPx and SOD2 to a-tubulin are shown in the lower panel.
doi:10.1371/journal.pone.0036818.g003
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assay. The injection of the anti-Fas antibody Jo2 induced similar
degrees of hepatocellular apoptosis in control mice and HBV
transgenic mice (Fig. S2). The enzyme activities of GPx and SOD2
were lower in HBV transgenic mice than in control mice after
anti-Fas antibody injection (Table 2). The protein levels of GPx
and SOD2 are shown in Fig. S3. Aconitase can be inactivated by
ROS and therefore its activity has been used as an indirect
indicator of ROS [28]. We measured the aconitase activities of
control and HBV transgenic mice injected with Jo2. The aconitase
activity of HBV transgenic mice was 10% lower than that of
control mice (Fig. S4), indicating that a compromised antioxidant
system facilitates ROS production. Activation of JNK was
observed in both control and HBV transgenic mice after anti-
Fas antibody injection compared to the mice injected with saline,
and the activation of JNK was more pronounced in HBV
transgenic mice than in control mice when the mice were injected
with the anti-Fas antibody (Fig. 4A). Quantification of activation of
JNK is shown in Fig. 4B.
Enhancement of Fas-mediated activation of caspases 8
and 6 in HBV transgenic mice
Although we did not observe the difference of hepatocellular
apoptosis using a TUNEL assay between control and HBV
transgenic mice, we analyzed activation of caspases, since
activation of caspases occurs earlier than DNA fragmentation
during apoptosis. Caspase 8 is the initiator caspase of Fas-triggered
apoptosis and its autoproteolysis is essential for Fas-induced
apoptosis [29,30]. As shown in Fig. 5A, the cleaved caspase 8
(43 kD and 18 kD) was detected in HBV transgenic and control
mice after being intravenously injected with anti-Fas antibody Jo2,
but not in mice injected with saline. The cleaved p18 of caspase 8
was more pronounced in HBV transgenic mice than in control
mice, indicating that HBV could sensitize hepatocytes to Fas
signaling. To confirm this result, we analyzed the cleavage of
caspase 6, which can also be triggered by the activation of Fas
[31]. As shown in Fig. 5B, there was an increased level of cleaved
caspase 6 in HBV transgenic mice than in control mice after the
anti-Fas antibody injection. Caspase 6 is thought to be an effector
caspase because it can cleave the nuclear structural protein NuMA
and the lamin proteins. However, it has also been shown that
caspase 6 cleaves itself, caspase 3 and 8 [32]. This result was
consistent with the activation of caspase 8 and further indicated
that HBV could sensitize hepatocytes to Fas signaling. Interest-
ingly, caspase 3, the downstream effector of caspase 8 and 6, was
activated to a lesser degree in HBV transgenic mice than in control
mice, as revealed by the similar levels of the cleaved p17 of caspase
3 and diminished levels of cleaved p19 and the cleaved poly ADP-
ribose polymerase (PARP), which is the downstream target of
caspase 3 (Fig. 5C). As HBV could enhance the activation of
caspases 8 and 6 and not enhance the activation of caspase 3 or
Fas-mediated hepatocellular apoptosis, HBV apparently could
enhance only the early apoptotic pathways in response to Jo2.
Discussion
Our recent studies indicate that HBV could contribute directly
to the development of HCC [19]. To date, the precise
pathogenetic mechanisms linking HBV infection and HCC
remain uncertain [14,33]. With our HBV transgenic mouse
model, we observed JNK activation in HBV transgenic mice,
which developed HCC. This result is consistent with the result
observed in human HCC, among which 70% were HBV positive
[12]. Concomitant with JNK activation, antioxidant enzymes GPx
and SOD2 were down-regulated in HBV transgenic mice. Down-
regulation of GPx and SOD2 may compromise the ability to cope
with ROS production in the liver of HBV transgenic mice. TNFa-
induced ROS accumulation leads to sustained JNK activation due
to lack of SOD2 in NFkB-deficient cells and oxidant paraquat can
promote JNK activation in the liver of GPx-deficient mice [7,11].
Figure 4. Fas-mediated activation of JNK in HBV transgenic mice. (A) Western blot analysis of activation of JNK in HBV transgenic mice and
control mice. i.v. injected with PBS or anti-Fas antibody Jo2. (B) Quantification of activation of JNK1 and JNK2 in HBV transgenic mice and control mice
as described in (A).
doi:10.1371/journal.pone.0036818.g004
Table 2. Enzyme activities of GPx and SOD2 in the liver of
control and HBV transgenic mice intravenously injected with
anti-Fas antibody Jo2.
GPx SOD2
(U/mg protein) (U/mg protein)
Control-1 2.160.1 5.460.5
Control-2 2.160.0 6.760.1
tg-1 1.260.3 4.560.0
tg-2 0.860.5 3.760.1
Values are mean 6 SD. tg=HBV transgenic mice.
doi:10.1371/journal.pone.0036818.t002
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factor (PDGF) signaling [34], epidermal growth factor (EGF)
signaling [35], insuling signaling [36] and vascular endothelial
growth factor (VEGF) signaling [37]. However, excessive ROS is
toxic and proper ROS level is important for maintaining cellular
homeostasis [1,38,39,40]. As HBV transgenic mice were intrave-
nously injected with anti-Fas antibody, which can induce ROS
production in the liver of the mouse [27], we observed that JNK
was activated more profoundly in the liver of HBV transgenic
mice and correlated with the lower activities of GPx and SOD2.
We observed JNK activation and down-regulation of GPx and
SOD2 only in 2-year old HBV transgenic mice, but not in 9-
month and younger mice (data not shown). Increasing age has
been recognized as a correlate of decrease in response to liver
injury and poor outcome in chronic liver disorders [41].
Decreased antioxidant defenses including the protein levels of
antioxidant enzymes are associated with aging, and thus sensitize
the cells, organs and organisms to oxidative damage [16,42,43,44].
The down-regulation of GPx and SOD2 in HBV mice with old
age indicated that the combination of HBV infection and aging
may lead to accelerated damage of antioxidant system and
hepatocarcinogenesis.
Caspase 8 is required for Fas-induced JNK activation [45,46].
Caspase 6 can cleave caspase 8 [32]. These enzymes play
important roles in the promotion of apoptosis. The injection of
the anti-Fas antibody Jo2 generated a stronger activation response
of caspase 8, caspase 6 and JNK in HBV transgenic mice than in
control mice. Interestingly, in spite of the activation of these
enzymes, there was no increased activation of caspase 3 or
apoptosis in the liver of HBV transgenic mice. These results
indicated that HBV could sensitize hepatocytes to Fas ligands to
elicit a partial apoptotic response but it was not able to sensitize
hepatocytes to apoptosis induced by Fas. Our results are
reminiscent of previous reports, which indicated that the anti-
Fas antibody could induce higher plasma alanine transaminase
(ALT) values in Gpx2/2 mice than in wild-type mice without
increasing the caspase 3 activities [6]. Since GPx was down-
regulated by HBV, it is conceivable that this reduction of GPx
activity by HBV may be partially responsible for the lack of
enhancement of caspase 3 activation. It has also been reported
that HBx protein can protect cells from Fas-induced apoptosis and
this protection requires activation of JNK [47,48]. HBx protein
may be another reason for the lack of enhanced caspase 3
activation.
In conclusion, our results demonstrated that HBV could affect
the antioxidant enzymes in the mouse liver and sensitize
hepatocytes to Fas signaling. This alteration of the antioxidant
system and the sensitization to Fas signaling may contribute to
hepatocarcinogenesis induced by HBV.
Materials and Methods
Mice
HBV transgenic mice used in this study have been described
previously [20]. These mice were backcrossed to C57BL/6J for at
least 6 generations. The mice were housed in the animal facility at
the Veterans Affairs Medical Center, San Francisco (VAMCSF).
All procedures were approved by the Institutional Animal Care
and Use Committee (IACUC) at the VAMCSF and carried out in
accordance with the IACUC policies. To study the effect of the
anti-Fas antibody, mice were intravenously (i.v.) injected with
120 ml phosphate buffered saline (PBS) with or without Jo2
antibody (0.6 mg/kg, BD Pharmingen). Two and a half hours
after injection, mice were euthanized with carbon dioxide (CO2),
followed by cervical dislocation. The liver tissues were removed,
rinsed with PBS, and either fixed in 10% buffered formalin (Fisher)
for TUNEL (terminal deoxynucleotidyl transferase dUTP nick end
labeling) assay and histological analyses or flash frozen in liquid
nitrogen and then stored at 280uC for Western blot and enzyme
assays. Apoptosis was detected by the TUNEL assay with the
Apop Tag Peroxidase In Situ Apoptosis Detection Kit (Millipore,
Cat. S7100).
Western blot analyses
Frozen liver tissues (20 mg) were washed in ice cold PBS, and
then homogenized at 4uCi n8 0ml 50 mM Tris-HCl (pH 8.0)
containing the protease inhibitor cocktail (Fermentas) and the
phosphatase inhibitor cocktail (Roche) with the Bullet Blender
machine (Next Advance Inc.). The tissue homogenates were
freeze-thawed 3 times to disrupt the mitochondrial membrane [5].
Protein concentrations of tissue homogenates were determined
with the Bradford assay (Bio-Rad). 5 to 40 mg protein was loaded
on a 4–20% SDS-PAGE gradient gel (TGX gel, Bio-Rad). Anti-
GPx (B-6) and anti-catalase (11A1) antibodies were purchased
from Santa Cruz Biotechnology; anti-SOD1 (Cat. AB5482) and
anti-SOD2 (Cat. 06-984) antibodies were purchased from
Millipore; anti-actin (Ab-1) mouse mAb (JLA20) was purchased
from Calbiochem. The apotosis antibody sampler kit (mouse
specific), the phospho- MAPK family antibody sampler kit, the
MAPK family antibody sampler kit, the anti-cleaved caspase-8
(Asp387) antibody (mouse specific), the anti-c-Jun antibody (60A8),
the anti-GAPDH (14C10) antibody, and the anti-a-tubulin
(11H10) antibody were all purchased from Cell Signaling
Technology. The goat anti-HBV surface antigen (Ad/Ay)
antibody was purchased from Abcam. All secondary antibodies
were purchased from Santa Cruz Biotechnology. Western blot
results were quantified using Image J (NIH) software.
Enzyme assays and lipid peroxidation assay
For all enzyme assays, the frozen liver tissues were washed with
ice cold PBS, and homogenized at 4uC in the buffers provided by
Figure 5. Fas-mediated activation of caspases 8, 6 and 3 in HBV
transgenic mice. (A) Western blot analysis of cleaved caspase 8. The
cleaved 43 kDa and 18 kDa caspase 8 protein bands are highlighted,
*non specific protein band. RI refers to the intensity of cleaved p43 and
p18 relative to that of actin. (B) Western blot analysis of cleaved caspase
6. RI refers to the intensity of caspase 6 relative to that of a-tubulin. (C)
Western blot analysis of cleaved caspase 3 and PARP. The cleaved
19 kDa and 17 kDa caspase 3 protein bands are highlighted. RI refers to
the intensity of cleaved p19, p17 and PARP relative to that of actin.
doi:10.1371/journal.pone.0036818.g005
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thawed 3 times using dry ice and room temperature water bath.
Protein concentrations were determined by the Bradford assay and
adjusted to 0.5 mg/ml. GPx activities were determined with the
Glutathione Peroxidase Cellular Activity Assay Kit (Sigma-
Aldrich, Cat. CGP1). SOD activities were determined with the
SOD Determination Kit (Sigma-Aldrich, Cat. 19160). The GPx
standard (glutathione peroxidase from bovine erythrocytes) and
SOD standard (superoxide dismutase from human erythrocytes,
Cat. S9636) were purchased from Sigma-Aldrich. To determine
the SOD2 activities, the homogenates were incubated with
potassium cyanide (final concentration 5 mM) for 30 min at room
temperature to inactivate SOD1 [2,21]. Aconitase activities were
determined with Aconitase Assay Kit (Cayman Chemical Com.,
Cat. 705502). The lipid peroxidation levels were determined with
OxiSelect TBARS Assay Kit (MDA Quantification) (Cell Biolabs
Inc., Cat. STA-330). All the readings were performed with the
Modulus Microplate Multimode Plate Reader (Turner BioSys-
tems). All the enzymatic activities measured were normalized to
the protein concentrations.
Plasmids, cell culture and transfection
The pHBV1.3 plasmid contains the 1.3mer over-length
HBVgenome in the pUC19 vector. This plasmid contains the
entire HBV genome plus a terminal redundancy of nearly 1 kb
[22]. Human hepatoma cell line C3A was purchased from
American Type Culture Collection (ATCC) and cultured in
Eagle’s Minimum Essential (MEM) medium supplemented with
non-essential amino acids, 2 mM L-glutamine, 1 mM sodium
pyruvate, 1.5 g/L sodium bicarbonate and 10% fetal bovine
serum at 37uCi n5 %C O 2. C3A cells (1.5610
5) were seeded into
24-well plates. The cells were transfected with 400 ng pUC19 or
pHBV1.3 using the FuGENE HD transfection reagent (Roche).
Forty-eight hours post transfection, cells were trypsinized, washed
with PBS and lysed in the RIPA buffer (1% Nonidet P-40, 0.25%
sodium deoxycholate, 150 mM NaCl, and 50 mM Tris-HCl
pH 7.4) containing the protease inhibitor cocktail (Fermentas) and
the phosphatase inhibitor cocktail (Roche). After a brief centrifu-
gation to remove cell debris, the supernatants were collected for
Western blot analysis.
Statistical analysis
Student’s t- test was used to analyze the data. P values were
calculated in individual assays and P,0.05 was considered as
statistically significant.
Supporting Information
Figure S1 The representative hematoxylin and eosin
stained sections. (A) Non-tg control mouse liver section. (B)
HBV tg mouse liver section with HCC.
(TIF)
Figure S2 Mouse liver apoptosis detected by TUNEL
assay. (A) Non-tg control mouse was i.v. injected with 120 ml
PBS. (B) HBV transgenic mouse was i.v. injected with 120 ml PBS.
(C–D) Two non-tg control mice were i.v. injected with anti-Fas
antibody Jo2 (0.6 mg/kg) in 120 ml PBS. (E–F) Two HBV tg mice
were i.v. injected with anti-Fas antibody Jo2 (0.6 mg/kg) in 120 ml
PBS. The mice were sacrificed 2.5 h post injection. Paraffin-
embedded liver samples were stained for apoptotic cells with
TUNEL assay. (G) The apoptotic cells in ten individual fields of
two non-tg control mice and two HBV tg mice were counted and
normalized to the surface area (mean 6 SD).
(TIF)
Figure S3 Protein levels of GPx and SOD2 in the liver of
non-transgenic control and HBV transgenic mice inject-
ed with Jo2. (A) Western blot analysis of GPx in the liver of
control and HBV transgenic mice. RI refers to the intensity of GPx
normalized to that of a-tubulin, which was used as the loading
control. (B) Western blot analysis of SOD2 in the liver of control
and HBV transgenic mice. RI refers to the intensity of SOD2
relative to that of a-tubulin.
(TIF)
Figure S4 Analysis of aconitase activities in the liver of
control and HBV transgenic mice injected with Jo2.
Aconitase activities were measured in two control and two HBV tg
mice and normalized to the protein concentrations. The aconitase
activity of control mice were arbitrarily defined as 100% (mean 6
SD).
(TIF)
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